Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

3 articles matching "genetic testing"

AdvocacyRSS2 days ago

Why Early Genetic Testing in TK2d Changes Everything

A parent shares their experience with their son's delayed diagnosis of thymidine kinase 2 deficiency (TK2d), a rare genetic disorder affecting how the body uses certain building blocks for DNA. The article highlights how early genetic testing could have identified the condition sooner and made a significant difference in the child's care and outcomes. Early testing is important because it allows doctors to start treatment and management strategies before serious complications develop.

WHY IT MATTERSParents of children with unexplained developmental delays or muscle weakness can use this story to advocate for early genetic testing with their doctors, potentially catching TK2d before irreversible damage occurs.
💬 Ask your doctorthymidine kinase 2 deficiencyRead →
PolicyRSS2 days ago

Understanding genetic counseling in ALS

Doctors are now recommending that all ALS patients get genetic testing to understand if their disease is inherited. A genetic counselor is a specialist who helps explain what these test results mean and how they might affect family members. Understanding your genetic information can help you and your doctor make better decisions about your care and family planning.

WHY IT MATTERSIf you have ALS, genetic testing and counseling can reveal whether your condition is hereditary, which affects whether your relatives should be screened and what treatment options might work best for you.
💬 Ask your doctorAmyotrophic Lateral SclerosisRead →
PolicyPUBMEDMar 26

Genomic pathway managers: a novel role in the genomic medicine care pathway in France-overview and perspectives.

France is creating a new type of healthcare worker called a Genomic Pathway Manager to help doctors order genetic tests for patients with rare diseases and cancer. These managers will make it easier for patients to get genetic testing by organizing the process and helping doctors understand when and how to use these tests. The goal is to make genetic testing available to more people across France starting in 2025.

WHY IT MATTERSIf you have a rare disease in France, this new system could help your doctor identify your condition faster through genetic testing, potentially leading to earlier diagnosis and treatment options.
Good to knowrare diseases (general)cancer genetic predispositionRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases